Literature DB >> 7522535

Isochromosomes in neoplasia.

F Mertens1, B Johansson, F Mitelman.   

Abstract

In order to ascertain the frequency and distribution of isochromosomes in neoplasia, we surveyed the cytogenetic data from 20,007 tumors with clonal chromosome aberrations reported in the literature. Tumor types for which at least 50 cases with acquired aberrations and 10 cases with isochromosomes had been reported were selected, yielding a total of 18,160 neoplasms. Of these, 1,792 cases (9.9%) displayed a total of 2,014 isochromosomes. The 9 most common isochromosomes (detected in at least 50 cases) were, in decreasing order of frequency, i(17q), i(8q), i(1q), i(12p), i(6p), i(7q), i(9q), i(5p), and i(21q). The frequency of isochromosomes varied among the different tumor types, with the highest incidence in germ cell neoplasms (60%) and the lowest in chronic myeloproliferative disorders (2.3%). Also, the spectrum of isochromosomes differed among the neoplasms. The most common isochromosomes in the different tumor types were i(11q), i(17q), and i(21q) in acute myeloid leukemia; i(9q), i(17q), and i(22q) in chronic myeloid leukemia; i(17q) in chronic myeloproliferative disorders; i(X)(q13), i(17q), and i(21q) in myelodysplastic syndromes; i(7q), i(9q), and i(17q) in acute lymphoblastic leukemia; i(1q), i(7q), i(8q), and i(17q) in chronic lymphoproliferative disorders; i(1q), i(6p), i(9p), i(17q), and i(21q) in Hodgkin's disease; i(1q), i(6p), and i(17q) in non-Hodgkin's lymphoma; i(1q), i(8q), and i(17q) in adenocarcinoma; i(1q), i(3q), i(5p), and i(8q) in squamous cell carcinoma; i(5p), i(8q), and i(11q) in transitional cell carcinoma; i(1q), i(7q), and i(17q) in Wilms' tumor; i(1q), i(12p), and i(17q) in germ cell neoplasms; i(1p), i(1q), i(6p), and i(17q) in sarcoma; i(5p), i(6p), i(7p), and i(21q) in mesothelioma; i(1q), i(6p), and i(17q) in malignant neurogenic neoplasms; i(1q), i(6p), and i(17q) in retinoblastoma; and i(1q), i(6p), and i(8q) in malignant melanoma.

Entities:  

Mesh:

Year:  1994        PMID: 7522535     DOI: 10.1002/gcc.2870100402

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  34 in total

1.  Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7.

Authors:  S Goobie; M Popovic; J Morrison; L Ellis; H Ginzberg; G R Boocock; N Ehtesham; C Bétard; C G Brewer; N M Roslin; T J Hudson; K Morgan; T M Fujiwara; P R Durie; J M Rommens
Journal:  Am J Hum Genet       Date:  2001-03-15       Impact factor: 11.025

2.  Genome architecture catalyzes nonrecurrent chromosomal rearrangements.

Authors:  Paweł Stankiewicz; Christine J Shaw; Jason D Dapper; Keiko Wakui; Lisa G Shaffer; Marjorie Withers; Leah Elizondo; Sung-Sup Park; James R Lupski
Journal:  Am J Hum Genet       Date:  2003-03-20       Impact factor: 11.025

3.  The landscape of myeloid neoplasms with isochromosome 17q discloses a specific mutation profile and is characterized by an accumulation of prognostically adverse molecular markers.

Authors:  M Meggendorfer; C Haferlach; M Zenger; K Macijewski; W Kern; T Haferlach
Journal:  Leukemia       Date:  2016-02-09       Impact factor: 11.528

4.  A novel case of extreme thrombocytosis in acute myeloid leukemia associated with isochromosome 17q and copy neutral loss of heterozygosity.

Authors:  Eunkyoung You; Sun Young Cho; John Jeongseok Yang; Hee Joo Lee; Woo-In Lee; Juhie Lee; Kyung Sam Cho; Eun Hae Cho; Tae Sung Park
Journal:  Ann Lab Med       Date:  2015-04-01       Impact factor: 3.464

5.  Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.

Authors:  Johanna Oltmann; Kerstin Heselmeyer-Haddad; Leanora S Hernandez; Rüdiger Meyer; Irianna Torres; Yue Hu; Natalie Doberstein; J Keith Killian; David Petersen; Yuelin Jack Zhu; Daniel C Edelman; Paul S Meltzer; Russell Schwartz; E Michael Gertz; Alejandro A Schäffer; Gert Auer; Jens K Habermann; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2018-01-09       Impact factor: 5.006

Review 6.  Tumor suppressor genes and medulloblastoma.

Authors:  P H Cogen; J D McDonald
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

7.  UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.

Authors:  Youfeng Yang; Vladimir A Valera; Hesed M Padilla-Nash; Carole Sourbier; Cathy D Vocke; Manish A Vira; Mones S Abu-Asab; Gennady Bratslavsky; Maria Tsokos; Maria J Merino; Peter A Pinto; Ramaprasad Srinivasan; Thomas Ried; Len Neckers; W Marston Linehan
Journal:  Cancer Genet Cytogenet       Date:  2010-01-01

8.  The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats.

Authors:  Aikaterini Barbouti; Pawel Stankiewicz; Chad Nusbaum; Christina Cuomo; April Cook; Mattias Höglund; Bertil Johansson; Anne Hagemeijer; Sung-Sup Park; Felix Mitelman; James R Lupski; Thoas Fioretos
Journal:  Am J Hum Genet       Date:  2003-12-08       Impact factor: 11.025

9.  Rad51 suppresses gross chromosomal rearrangement at centromere in Schizosaccharomyces pombe.

Authors:  Ken-ichi Nakamura; Aya Okamoto; Yuki Katou; Chie Yadani; Takeshi Shitanda; Chitrada Kaweeteerawat; Tatsuro S Takahashi; Takehiko Itoh; Katsuhiko Shirahige; Hisao Masukata; Takuro Nakagawa
Journal:  EMBO J       Date:  2008-10-16       Impact factor: 11.598

10.  Loss of spindle assembly checkpoint-mediated inhibition of Cdc20 promotes tumorigenesis in mice.

Authors:  Min Li; Xiao Fang; Zhubo Wei; J Philippe York; Pumin Zhang
Journal:  J Cell Biol       Date:  2009-06-15       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.